Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PLASMACYTOMA”

133 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 133 results

Testing effectiveness (Phase 2)Study completedNCT03773107
What this trial is testing

LCI-HEM-MYE-CRD-004 (MMRC-073 CARJAK): Study of CRD for Carfilzomib-Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Wake Forest University Health Sciences 12
Not applicableStudy completedNCT00900055
What this trial is testing

Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma

Who this might be right for
Chronic Myeloproliferative DisordersFanconi AnemiaMultiple Myeloma and Plasma Cell Neoplasm+1 more
OHSU Knight Cancer Institute 213
Not applicableEnded earlyNCT00726830
What this trial is testing

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07705074
What this trial is testing

FAPI PET Imaging - An Exploratory Study

Who this might be right for
Thyroid PathologyHead and Neck Cancer (H&N)Sinonasal Tract Tumor+14 more
Martin Huellner 770
Large-scale testing (Phase 3)Looking for participantsNCT07319897
What this trial is testing

68Ga-BCMA PET/CT in Multiple Myeloma

Who this might be right for
Multiple MyelomaMultiple Myeloma and Malignant Plasma Cell NeoplasmsMultiple Myeloma and Plasma Cell Neoplasm
Peking University First Hospital 300
Testing effectiveness (Phase 2)Ended earlyNCT03312868
What this trial is testing

Stereotactic Body Radiotherapy for the Treatment of Solitary Bone Plasmacytoma

Who this might be right for
Plasmacytoma
Instituto do Cancer do Estado de São Paulo 10
Testing effectiveness (Phase 2)UnknownNCT04065308
What this trial is testing

Daratumumab With DCEP for Multiple Myeloma With Plasmacytoma

Who this might be right for
Multiple Myeloma in RelapsePlasmacytomaDaratumumab
Seoul National University Hospital 33
Very early researchLooking for participantsNCT07519187
What this trial is testing

CAR 70-BCMA CAR-T Cells for the Treatment of Relapsed or Refractory Plasma Cell Neoplasms

Who this might be right for
Relapsed or Refractory Plasma Cell Neoplasms
The General Hospital of Western Theater Command 20
Not applicableStudy completedNCT05260203
What this trial is testing

MargheRITA (Remote Intelligence for Therapeutic Adherence)

Who this might be right for
Multiple MyelomaSolitary PlasmacytomaAmyloidosis+11 more
Advice Pharma Group srl 124
Not applicableStudy completedNCT00569868
What this trial is testing

UARK 2005-05, Coagulation-Related Effects of Velcade Treatment in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
MULTIPLE MYELOMA
University of Arkansas 11
Testing effectiveness (Phase 2)Study completedNCT00002657
What this trial is testing

SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant

Who this might be right for
LymphomaMultiple Myeloma and Plasma Cell Neoplasm
SWOG Cancer Research Network 20
Testing effectiveness (Phase 2)Study completedNCT01946477
What this trial is testing

Pomalidomide in Combination With Low-dose Dexamethasone or Pomalidomide in Combination With Low-dose Dexamethasone and Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma Following Lenalidomide-based Therapy in the First or Second Line Setting

Who this might be right for
Multiple Myeloma
Celgene 186
Not applicableWithdrawnNCT00499668
What this trial is testing

Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer

Who this might be right for
Myeloproliferative DisordersLeukemiaLymphoma+5 more
Vanderbilt-Ingram Cancer Center
Early research (Phase 1)Study completedNCT01248923
What this trial is testing

ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma, Plasma Cell Leukemia
Array Biopharma, now a wholly owned subsidiary of Pfizer 55
Testing effectiveness (Phase 2)Study completedNCT00005622
What this trial is testing

Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMultiple Myeloma and Malignant Plasma Cell Neoplasms+2 more
H. Lee Moffitt Cancer Center and Research Institute 72
Testing effectiveness (Phase 2)Study completedNCT00005797
What this trial is testing

Bone Marrow Transplant in Treating Patients With Hematologic Cancers

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMultiple Myeloma and Malignant Plasma Cell Neoplasms+2 more
H. Lee Moffitt Cancer Center and Research Institute 125
Early research (Phase 1)Study completedNCT00006362
What this trial is testing

PS-341 in Treating Patients With Advanced Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more
Mayo Clinic
Testing effectiveness (Phase 2)Looking for participantsNCT06863584
What this trial is testing

SBRT Plus Lenalidomide for Solitary Plasmacytoma: Phase II Trial

Who this might be right for
Solitary Plasmacytoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 41
Large-scale testing (Phase 3)Study completedNCT00005805
What this trial is testing

St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer

Who this might be right for
Chronic Myeloproliferative DisordersFatigueLeukemia+5 more
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Looking for participantsNCT07179679
What this trial is testing

A Clinical Study Assessing the Subcutaneous Formulation of TQB2934 for Injection in Subjects With Malignant Plasma Cell Tumors

Who this might be right for
Multiple Myeloma
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 42
Next Page